ID   TSPO2_CANLF             Reviewed;         172 AA.
AC   E2RDM9; A0A6M3RDU1; A0A6M3RRT7;
DT   02-DEC-2020, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 1.
DT   10-FEB-2021, entry version 48.
DE   RecName: Full=Translocator protein 2 {ECO:0000303|PubMed:32358067};
GN   Name=TSPO2 {ECO:0000303|PubMed:32358067};
OS   Canis lupus familiaris (Dog) (Canis familiaris).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae; Canis.
OX   NCBI_TaxID=9615 {ECO:0000312|Proteomes:UP000002254};
RN   [1] {ECO:0000312|EMBL:QJD20749.1, ECO:0000312|EMBL:QJD20750.1, ECO:0000312|EMBL:QJD20751.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND CHARACTERIZATION OF VARIANTS HK TYR-40; PHE-89; PHE-98 DEL
RP   AND ILE-120.
RX   PubMed=32358067; DOI=10.1074/jbc.ra119.011679;
RA   Kiatpakdee B., Sato K., Otsuka Y., Arashiki N., Chen Y., Tsumita T.,
RA   Otsu W., Yamamoto A., Kawata R., Yamazaki J., Sugimoto Y., Takada K.,
RA   Mohandas N., Inaba M.;
RT   "Cholesterol-binding protein TSPO2 coordinates maturation and proliferation
RT   of terminally differentiating erythroblasts.";
RL   J. Biol. Chem. 295:8048-8063(2020).
RN   [2] {ECO:0000312|Proteomes:UP000002254}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Boxer {ECO:0000312|Proteomes:UP000002254};
RX   PubMed=16341006; DOI=10.1038/nature04338;
RA   Lindblad-Toh K., Wade C.M., Mikkelsen T.S., Karlsson E.K., Jaffe D.B.,
RA   Kamal M., Clamp M., Chang J.L., Kulbokas E.J. III, Zody M.C., Mauceli E.,
RA   Xie X., Breen M., Wayne R.K., Ostrander E.A., Ponting C.P., Galibert F.,
RA   Smith D.R., deJong P.J., Kirkness E.F., Alvarez P., Biagi T., Brockman W.,
RA   Butler J., Chin C.-W., Cook A., Cuff J., Daly M.J., DeCaprio D., Gnerre S.,
RA   Grabherr M., Kellis M., Kleber M., Bardeleben C., Goodstadt L., Heger A.,
RA   Hitte C., Kim L., Koepfli K.-P., Parker H.G., Pollinger J.P.,
RA   Searle S.M.J., Sutter N.B., Thomas R., Webber C., Baldwin J., Abebe A.,
RA   Abouelleil A., Aftuck L., Ait-Zahra M., Aldredge T., Allen N., An P.,
RA   Anderson S., Antoine C., Arachchi H., Aslam A., Ayotte L., Bachantsang P.,
RA   Barry A., Bayul T., Benamara M., Berlin A., Bessette D., Blitshteyn B.,
RA   Bloom T., Blye J., Boguslavskiy L., Bonnet C., Boukhgalter B., Brown A.,
RA   Cahill P., Calixte N., Camarata J., Cheshatsang Y., Chu J., Citroen M.,
RA   Collymore A., Cooke P., Dawoe T., Daza R., Decktor K., DeGray S.,
RA   Dhargay N., Dooley K., Dooley K., Dorje P., Dorjee K., Dorris L.,
RA   Duffey N., Dupes A., Egbiremolen O., Elong R., Falk J., Farina A., Faro S.,
RA   Ferguson D., Ferreira P., Fisher S., FitzGerald M., Foley K., Foley C.,
RA   Franke A., Friedrich D., Gage D., Garber M., Gearin G., Giannoukos G.,
RA   Goode T., Goyette A., Graham J., Grandbois E., Gyaltsen K., Hafez N.,
RA   Hagopian D., Hagos B., Hall J., Healy C., Hegarty R., Honan T., Horn A.,
RA   Houde N., Hughes L., Hunnicutt L., Husby M., Jester B., Jones C., Kamat A.,
RA   Kanga B., Kells C., Khazanovich D., Kieu A.C., Kisner P., Kumar M.,
RA   Lance K., Landers T., Lara M., Lee W., Leger J.-P., Lennon N., Leuper L.,
RA   LeVine S., Liu J., Liu X., Lokyitsang Y., Lokyitsang T., Lui A.,
RA   Macdonald J., Major J., Marabella R., Maru K., Matthews C., McDonough S.,
RA   Mehta T., Meldrim J., Melnikov A., Meneus L., Mihalev A., Mihova T.,
RA   Miller K., Mittelman R., Mlenga V., Mulrain L., Munson G., Navidi A.,
RA   Naylor J., Nguyen T., Nguyen N., Nguyen C., Nguyen T., Nicol R., Norbu N.,
RA   Norbu C., Novod N., Nyima T., Olandt P., O'Neill B., O'Neill K., Osman S.,
RA   Oyono L., Patti C., Perrin D., Phunkhang P., Pierre F., Priest M.,
RA   Rachupka A., Raghuraman S., Rameau R., Ray V., Raymond C., Rege F.,
RA   Rise C., Rogers J., Rogov P., Sahalie J., Settipalli S., Sharpe T.,
RA   Shea T., Sheehan M., Sherpa N., Shi J., Shih D., Sloan J., Smith C.,
RA   Sparrow T., Stalker J., Stange-Thomann N., Stavropoulos S., Stone C.,
RA   Stone S., Sykes S., Tchuinga P., Tenzing P., Tesfaye S., Thoulutsang D.,
RA   Thoulutsang Y., Topham K., Topping I., Tsamla T., Vassiliev H.,
RA   Venkataraman V., Vo A., Wangchuk T., Wangdi T., Weiand M., Wilkinson J.,
RA   Wilson A., Yadav S., Yang S., Yang X., Young G., Yu Q., Zainoun J.,
RA   Zembek L., Zimmer A., Lander E.S.;
RT   "Genome sequence, comparative analysis and haplotype structure of the
RT   domestic dog.";
RL   Nature 438:803-819(2005).
CC   -!- FUNCTION: Cholesterol-binding protein involved in the redistribution of
CC       cholesterol from lipid droplets to the endoplasmic reticulum
CC       (PubMed:32358067). Required to meet cholesterol demands during
CC       erythropoietic differentiation (PubMed:32358067). May play a role in
CC       transport processes at the plasma membrane of erythrocytes, including
CC       regulating VDAC-mediated ATP export, and import of the heme precursors
CC       protoporphyrin IX and 5-aminolevulinic acid (By similarity).
CC       {ECO:0000250|UniProtKB:Q5TGU0, ECO:0000269|PubMed:32358067}.
CC   -!- SUBUNIT: Homotetramer. May also form homodimer.
CC       {ECO:0000250|UniProtKB:Q5TGU0}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q5TGU0}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell membrane {ECO:0000269|PubMed:32358067}; Multi-pass
CC       membrane protein {ECO:0000255}. Note=Localizes to the plasma membrane
CC       and intracellular membranes in developing and mature erythrocytes.
CC       {ECO:0000250|UniProtKB:Q5TGU0}.
CC   -!- TISSUE SPECIFICITY: Expressed in erythrocytes (at protein level).
CC       {ECO:0000269|PubMed:32358067}.
CC   -!- DOMAIN: The C-terminal region mediates cholesterol-binding.
CC       {ECO:0000250|UniProtKB:Q9CRZ8}.
CC   -!- DISEASE: Note=Defects in TSPO2 functioning alter the cation composition
CC       of canine erythrocytes so that they are high in potassium and low in
CC       sodium (HK phenotype) (PubMed:32358067). Although HK erythrocytes have
CC       a tendency to hemolyze they do not cause serious disease, but the
CC       phenotype may lead to misdiagnosis of hyperkalemia in HK canines and
CC       blood transfusions using HK blood may induce hyperkalemia
CC       (PubMed:32358067). This phenotype has been identified in the Shiba
CC       breed (PubMed:32358067). {ECO:0000269|PubMed:32358067}.
CC   -!- SIMILARITY: Belongs to the TspO/BZRP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN397823; QJD20749.1; -; mRNA.
DR   EMBL; MN397824; QJD20750.1; -; mRNA.
DR   EMBL; MN397825; QJD20751.1; -; mRNA.
DR   EMBL; AAEX03008323; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   STRING; 9612.ENSCAFP00000002289; -.
DR   PaxDb; E2RDM9; -.
DR   Ensembl; ENSCAFT00030012352; ENSCAFP00030010806; ENSCAFG00030006716.
DR   Ensembl; ENSCAFT00040043569; ENSCAFP00040038005; ENSCAFG00040023442.
DR   eggNOG; KOG3797; Eukaryota.
DR   HOGENOM; CLU_091805_2_1_1; -.
DR   InParanoid; E2RDM9; -.
DR   OMA; WLAMATC; -.
DR   OrthoDB; 1592225at2759; -.
DR   TreeFam; TF342852; -.
DR   Proteomes; UP000002254; Chromosome 12.
DR   Bgee; ENSCAFG00000001574; Expressed in spleen and 11 other tissues.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0015485; F:cholesterol binding; IBA:GO_Central.
DR   GO; GO:0089718; P:amino acid import across plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043353; P:enucleate erythrocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0098739; P:import across plasma membrane; ISS:UniProtKB.
DR   GO; GO:0032367; P:intracellular cholesterol transport; IMP:UniProtKB.
DR   GO; GO:0034389; P:lipid droplet organization; IMP:UniProtKB.
DR   CDD; cd15904; TSPO_MBR; 1.
DR   Gene3D; 1.20.1260.100; -; 1.
DR   InterPro; IPR038330; TspO/MBR-related_sf.
DR   InterPro; IPR004307; TspO_MBR.
DR   PANTHER; PTHR10057; PTHR10057; 1.
DR   Pfam; PF03073; TspO_MBR; 1.
DR   PIRSF; PIRSF005859; PBR; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disease variant; Endoplasmic reticulum; Membrane; Receptor;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..172
FT                   /note="Translocator protein 2"
FT                   /id="PRO_0000451410"
FT   TRANSMEM        3..23
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        45..65
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        80..100
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        104..124
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        130..150
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   VARIANT         40
FT                   /note="C -> Y (in HK; decreases TSPO2 expression levels.
FT                   Abnormal chromosome condensation and chromosome segregation
FT                   in differentiating erythrocytes, resulting in abnormal
FT                   cytokinesis and differentiation)"
FT                   /evidence="ECO:0000269|PubMed:32358067"
FT   VARIANT         89
FT                   /note="V -> F (in HK; associated in cis with F-98 DEL and
FT                   I-120; decreases TSPO2 expression levels)"
FT                   /evidence="ECO:0000269|PubMed:32358067"
FT   VARIANT         98
FT                   /note="Missing (in HK; associated in cis with F-89 and I-
FT                   120; decreases TSPO2 expression levels)"
FT                   /evidence="ECO:0000269|PubMed:32358067"
FT   VARIANT         120
FT                   /note="T -> I (in HK; associated in cis with F-89 and F-98
FT                   DEL; decreases TSPO2 expression levels)"
FT                   /evidence="ECO:0000269|PubMed:32358067"
SQ   SEQUENCE   172 AA;  19357 MW;  F5746F1570C35888 CRC64;
     MQPQGAIFVA LPHLGPILVS LLTRHRMIRW YDIPKKPPWC PPHKVLLAGW ITIYFVMGYA
     SYLVWKDLGG GFGRPLALPL GLYAVQLAVS WAVLIFFFAA HAHGLALLHM LLLYGLVVST
     ALIWHPINKL AAVLLLPYLA WLTVTASIAY HLWRDSLCPN HHQPLPMGEK RD
//
